Navigation Links
Video of EpiDerm Skin Irritation Test (SIT) Method Now Available

ASHLAND, Mass., July 23 /PRNewswire/ -- MatTek Corp., today announced the availability of a video version of its 2008 ECVAM-validated EpiDerm(TM) SIT non-animal alternative test method for determining the human skin irritation potential of chemicals, including cosmetic and pharmaceutical ingredients.

This 20 minute video article was published in the Journal of Visualized Experiments (JoVE). Titled, "An In Vitro Skin Irritation Test (SIT) using the EpiDerm Reconstructed Human Epidermal (RHE) Model", this peer-reviewed, PubMed-indexed video article is now available for online viewing on both the MatTek (WWW.MATTEK.COM) and JoVE Web sites.

In the video, Dr. Helena Kandarova, a Senior Scientist at MatTek, demonstrates the detailed steps in the EpiDerm Skin Irritation Test (SIT) protocol. Dr. Kandarova, based in the European Union (EU), played a central role in developing this test method, which in 2007 was subjected to a blind validation trial among four EU and US-based laboratories. Dr. Kandarova noted, "The video format permits MatTek to demonstrate the procedure in great detail allowing for better understanding and faster implementation by lab personnel who are new to this type of non-animal test method."

John Sheasgreen, MatTek's President, explained the need for the video, "We knew the recent validation of the EpiDerm SIT method combined with a full ban on the use of animals for this test in the EU would create unprecedented demand from organizations worldwide for information on how to perform this test. To meet this need, we felt video was the best choice to distribute the information quickly, accurately and to as many scientists as possible."

"MatTek published in JoVE because we were impressed with JoVE's ability to produce a professional video that is peer-reviewed and indexed in PubMed," noted Dave Ingalls, Sales & Marketing Manager. "Peer-review and PubMed indexing will assure scientists that they are viewing an accurate representation of this ECVAM-validated method."

About MatTek - MatTek Corp. is the world's largest independent producer of in vitro human epithelial tissue equivalents. With over 15 years of publicly available QC data and over 400 technical references supporting our claim of "Unsurpassed Long-Term Tissue Reproducibility", MatTek human tissue equivalents are used in product development, claims substantiation (over 200 patent references cite the use of MatTek tissues), safety assessment, and drug discovery/development in many industries including Cosmetics, Personal Care, Household Products, Chemicals, Pharmaceuticals and Biotech.

SOURCE MatTek Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NYU physicists find way to explore microscopic systems through holographic video
2. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
3. Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
4. Video: Turning Hope Into Reality - VA Research to Restore Veterans Abilities
5. Impact Systems' Compliance-in-a-Box™ Video is Announced as "Be the Buzz of Bio" Contest Finalist
6. Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentle Nasal Rinse From the Seas of Northern France
7. Video: Accera Launches Axona(TM), First Medical Food Therapy to Help Manage Mild-to-Moderate Alzheimers Disease
8. Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin
9. BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on
10. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
11. New Video Streaming Site Created by Ambrose Video Publishing
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
Breaking Biology Technology:
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):